| [1] |
LI XY, HE C, ZHU Y, et al. Role of gut microbiota on intestinal barrier function in acute pancreatitis[J]. World J Gastroenterol, 2020, 26(18): 2187-2193. DOI: 10.3748/wjg.v26.i18.2187 |
| [2] |
BUREK J, JAWORSKA K, WITKOWSKI G, et al. A case of acute pancreatitis - does step-up protocol always indicated?[J]. Pol Merkur Lekarski, 2020, 48(284): 100-102.
|
| [3] |
LIU J, ZHANG B. The lived experience of inpatients with acute recurrent pancreatitis: A qualitative research study from west China[J]. Gastroenterol Nurs, 2020, 43(3): 249-257. DOI: 10.1097/SGA.0000000000000442 |
| [4] |
WANG J, HE W, TSAI PJ, et al. Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease[J]. Lipids Health Dis, 2020, 19(1): 72. DOI: 10.1186/s12944-020-01210-0 |
| [5] |
MITRA S, DE A, CHOWDHURY A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases[J]. Transl Gastroenterol Hepatol, 2020, 5: 16. DOI: 10.21037/tgh.2019.09.08 |
| [6] |
WONG SW, CHAN WK. Epidemiology of non-alcoholic fatty liver disease in Asia[J]. Indian J Gastroenterol, 2020, 39(1): 1-8. DOI: 10.1007/s12664-020-01018-x |
| [7] |
MIKOLASEVIC I, ORLIC L, POROPAT G, et al. Nonalcoholic fatty liver and the severity of acute pancreatitis[J]. Eur J Intern Med, 2017, 38: 73-78. DOI: 10.1016/j.ejim.2016.10.019 |
| [8] |
|
| [9] |
WORM N. Beyond body weight-loss: Dietary strategies targeting intrahepatic fat in NAFLD[J]. Nutrients, 2020, 12(5): e1316. DOI: 10.3390/nu12051316 |
| [10] |
SWEET PH, KHOO T, NGUYEN S. Nonalcoholic fatty liver disease[J]. Prim Care, 2017, 44(4): 599-607. DOI: 10.1016/j.pop.2017.07.003 |
| [11] |
MIKOLASEVIC I, MILIC S, ORLIC L, et al. Metabolic syndrome and acute pancreatitis[J]. Eur J Intern Med, 2016, 32: 79-83. DOI: 10.1016/j.ejim.2016.04.004 |
| [12] |
KAO WY, CHANG IW, CHEN CL, et al. Fibroscan-based score to predict significant liver fibrosis in morbidly obese patients with nonalcoholic fatty liver disease[J]. Obes Surg, 2020, 30(4): 1249-1257. DOI: 10.1007/s11695-019-04192-w |
| [13] |
JIN D, NIU CY. The effect of nonalcoholic fatty liver disease on the severity of acute pancreatitis[J]. J Prac Med, 2017, 33(21): 3563-3565.
金豆, 牛春燕. 非酒精性脂肪性肝病对急性胰腺炎严重程度的影响[J]. 实用医学杂志, 2017, 33(21): 3563-3565.
|
| [14] |
SZENTESI A, PARNICZKY A, VINCZE Á, et al. Multiple hits in acute pancreatitis: Components of metabolic syndrome synergize each other's deteriorating effects[J]. Front Physiol, 2019, 10: 1202. DOI: 10.3389/fphys.2019.01202 |
| [15] |
STEFANUTTI C, DI GIACOMO S, LABBADIA G. Timing clinical events in the treatment of pancreatitis and hypertriglyceridemia with therapeutic plasmapheresis[J]. Transfus Apher Sci, 2011, 45(1): 3-7. DOI: 10.1016/j.transci.2011.06.013 |
| [16] |
LI HL. Study on the relationship between obesity, diabetes, hyperlipidemia and acute pancreatitis[D]. Jinan: University of Shandong, 2016.
李慧丽. 肥胖、糖尿病、高脂血症与急性胰腺炎关系研究[D]. 济南: 山东大学, 2016.
|
| [17] |
KARPAVICIUS A, DAMBRAUSKAS Z, SILEIKIS A, et al. Value of adipokines in predicting the severity of acute pancreatitis: Comprehensive review[J]. World J Gastroenterol, 2012, 18(45): 6620-6627. DOI: 10.3748/wjg.v18.i45.6620 |
| [18] |
ZHONG R, YAN YF, JIANG X, et al. Clinical features of acute pancreatitis with metabolic syndrome and influencing factors for prognosis[J]. J Clin Hepatol, 2020, 36(8): 1794-1798. DOI: 10.3969/j.issn.1001-5256.2020.08.023 |
| [19] |
YOUNOSSI ZM, GOLABI P, de AVILA L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis[J]. Hepatol, 2019, 71(4): 793-801. DOI: 10.1016/j.jhep.2019.06.021 |
| [20] |
FUJⅡ H, KAWADA N, Japan Study Group of NAFLD. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease[J]. Int J Mol Sci, 2020, 21(11): 3863. DOI: 10.3390/ijms21113863 |
| [21] |
WANG YH, GAO Y. Research progress in diagnosis and treatment of non-alcoholic fatty liver disease combinated with type 2 diabetes mellitus[J]. J Jilin Univ (Med Edit), 2020, 46(6): 1324-1331.
王雨涵, 高影. 非酒精性脂肪性肝病并发2型糖尿病诊断和治疗的研究进展[J]. 吉林大学学报(医学版), 2020, 46(6): 1324-1331.
|
| [22] |
|
| [23] |
de PRETIS N, AMODIO A, FRULLONI L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management[J]. United European Gastroenterol J, 2018, 6(5): 649-655. DOI: 10.1177/2050640618755002 |
| [24] |
HOU S, TANG X, CUI H, et al. Fatty liver disease is associated with the severity of acute pancreatitis: A systematic review and meta-analysis[J]. Int J Surg, 2019, 65: 147-153. DOI: 10.1016/j.ijsu.2019.04.003 |
| [25] |
BHATIA M. Inflammatory response on the pancreatic acinar cell injury[J]. Scand J Surg, 2005, 94(2): 97-102. DOI: 10.1177/145749690509400203 |
| [26] |
ZHANG YH, DING SY. Analysis on relationship between non-alcoholic fatty liver disease and gallstone disease[J]. J Zhengzhou Univ(Med Sci), 2019, 54(5): 716-719.
张宇恒, 丁素英. 非酒精性脂肪肝与胆囊结石的关系分析[J]. 郑州大学学报(医学版), 2019, 54(5): 716-719.
|
| [27] |
HUANG Y, CHEN H. Research progress in association between nonalcoholic fatty liver disease and gallstone disease[J]. J Clin Hepatol, 2014, 30(11): 1217-1220. DOI: 10.3969/j.issn.1001-5256.2014.11.033 |
| [28] |
CHEN YF. An analysis of the prevalence and its risk factors of gallbladder diseases in patients with fatty liver disease[D]. Jinan: University of Jinan, 2014.
陈永芳. 脂肪肝合并胆囊疾病的患病率及对其危险因素的相关性分析[D]. 济南: 济南大学, 2014.
|
| [29] |
FENG L, ZHANG Y, XU DQ, et al. Progress in diagnosis and treatment of acute biliary pancreatitis[J]. Chin J Bases Clin General Surg, 2019, 26(4): 508-512.
冯磊, 张轶, 徐德全, 等. 急性胆源性胰腺炎诊治进展[J]. 中国普外基础与临床杂志, 2019, 26(4): 508-512.
|
| [30] |
BAFFY G. Kupffer cells in non-alcoholic fatty liver disease: The emerging view[J]. J Hepatol, 2009, 51(1): 212-223. DOI: 10.1016/j.jhep.2009.03.008 |
| [31] |
XU FZ, XIONG LY, WAN JY, et al. The role of Kupffer cells in nonalcoholic fatty liver disease[J]. Chem Life, 2019, 39(3): 464-471.
徐芳芷, 熊令伊, 万敬员, 等. Kupffer细胞在非酒精性脂肪肝病中的作用[J]. 生命的化学, 2019, 39(3): 464-471.
|
| [32] |
XU C, QIAO Z, LU Y, et al. Influence of fatty liver on the severity and clinical outcome in acute pancreatitis[J]. PLoS One, 2015, 10(11): e0142278. DOI: 10.1371/journal.pone.0142278 |
| [33] |
WANG Q, DU J, YU P, et al. Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis[J]. Sci Rep, 2015, 5: 17833. DOI: 10.1038/srep17833 |
| [34] |
WANG Q. Role of AAT decompensation in acute pancreatitis and its related molecular mechanism in hepatic steatosis[D]. Xi'an: The Fourth Military Medical University, 2016.
王谦. AAT失代偿在脂肪肝大鼠急性胰腺炎中的作用和机制研究[D]. 西安: 第四军医大学, 2016.
|
| [35] |
LI X, GUO X, JI H, et al. Relationships between metabolic comorbidities and occurrence, severity, and outcomes in patients with acute pancreatitis: A narrative review[J]. Biomed Res Int, 2019, 2019: 2645926. http://www.ncbi.nlm.nih.gov/pubmed/31687382 |
| [36] |
WANG Q, YAN H, WANG G, et al. RNA sequence analysis of rat acute experimental pancreatitis with and without fatty liver: A gene expression profiling comparative study[J]. Sci Rep, 2017, 7(1): 734. DOI: 10.1038/s41598-017-00821-5 |
| [37] |
CUI H, ZHANG X. Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: A literature review[J]. J Pediatr Endocrinol Metab, 2020, 33(5): 579-584. DOI: 10.1515/jpem-2019-0595 |
| [38] |
DUAN WL, ZHAO SZ, ZHAO L. Progress in the pathogenesis and treatment of non-alcoholic fatty liver disease[J]. J Log Univ CAPF(Med Sci), 2019, 28(8): 79-84.
段文丽, 赵淑珍, 赵莉. 非酒精性脂肪性肝病的发病机制及其治疗研究进展[J]. 武警后勤学院学报(医学版), 2019, 28(8): 79-84.
|
DownLoad: